Invention Grant
- Patent Title: Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
-
Application No.: US15179316Application Date: 2016-06-10
-
Publication No.: US09751927B2Publication Date: 2017-09-05
- Inventor: Ulrich Sensfuss , Thomas Kruse , Jesper F. Lau
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Leon Y. Lum
- Priority: EP13164272 20130418; EP13196656 20131211
- Main IPC: C07K14/605
- IPC: C07K14/605 ; A61K38/28 ; A61K31/26 ; A61K38/26
Abstract:
The invention relates to novel stable and protracted GLP-1/glucagon receptor co-agonists, to the use of said peptides in therapy, to methods of treatment comprising administration of said peptides to patients, and to the use of said peptides in the manufacture of medicaments.
Public/Granted literature
- US20160355562A1 STABLE, PROTRACTED GLP-1/GLUCAGON RECEPTOR CO-AGONISTS FOR MEDICAL USE Public/Granted day:2016-12-08
Information query
